Drawing based on the label description. No photo yet.
“150 mg are opaque pink cap and opaque pink body size "1" hard gelatin capsules imprinted with "H" on cap and "23" on body, filled with slightly yellow to yellowish granular powder.. Nilotinib capsules”
H 23 pill
Pill with imprint H 23 is pink, capsule, 19 mm and has been identified as Nilotinib 150 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Camber Pharmaceuticals, Inc.
Nilotinib 150 mg
- Imprint
- H 23
- Strength
- 150 mg
- Used for
- Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
- Color
- Pink
- Shape
- Capsule / oblong
- Size
- 19 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Camber Pharmaceuticals, Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 31722-779, 31722-779-33
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Nilotinib used for?
Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Adult Patients With Newly Diagnosed Ph+ CML-CP
Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP
Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
From the FDA-approved label on DailyMed (published Sep 30, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows H 23. The parts can be split between the two sides, so turn the pill over and check both.
- It is pink, capsule, 19 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Nilotinib
Inactive: Silicon Dioxide, Gelatin, Magnesium Stearate, Povidone K90, Sodium Lauryl Sulfate, Titanium Dioxide, Ferric Oxide Red, Anhydrous Dibasic Calcium Phosphate, Shellac, Propylene Glycol, Ammonia, Potassium Hydroxide, Ferrosoferric Oxide
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
724 par
Hydroxyurea 500 mg
Green & pink, capsule, 19 mm
Used for psoriasis and prostate cancer
-
AMNEAL 584
Temazepam 22.5 mg
Pink & white, capsule, 18 mm
Used for depression and panic disorder
Schedule IV
-
Y 562
Diltiazem Hydrochloride 120 mg
Pink, capsule, 19 mm
Used for high blood pressure and atrial fibrillation (irregular heartbeat)
-
Y 688
Diltiazem Hydrochloride 90 mg
Pink & yellow, capsule, 18 mm
Used for high blood pressure and atrial fibrillation (irregular heartbeat)
-
G 585
Aprepitant 125 mg
Pink & white, capsule, 19 mm
Used for nausea and vomiting
-
AMNEAL 803
Temozolomide 100 mg
Pink & white, capsule, 19 mm
Used for glioblastoma and melanoma
Other Nilotinib pills
- RDY 150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- MN4 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR BCR Nilotinib 150 mg Red, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- APO N150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- N12 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- Cipla 031150mg Nilotinib 150 mg Red, capsule, 20 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- RDY Nilotinib Hydrochloride Monohydrate 150 mg Red, capsule Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- RDY 200 Nilotinib 200 mg Yellow, capsule, 21 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia